The Bioinformatics Shared Resource, a core function of Duke Comprehensive Cancer:i_nstitute (DCCI}, supports the research needs of DCCI investigators (and secondarily, other Duke investigators) with respect to bioinformatics and complex data management and integration. Its mission is to provide a high-quality, service-oriented, coordinated, bioinformatics infrastructure for DCCI researchers, one.which increases collaborations across DCCI programs and between DCCI and other Duke programs.This core provides resources to DCCI programs and individual laboratories, coordinates institutional efforts in bioinformatics, helps drive the development of the biotechnology and pharmaceutical sectors withinDuke, and creates synergy between scientific and clinical groups. Services include state-of-the-art software to support a full range of research involving """"""""-omics"""""""" data, consultation and programming to assist with study design and analysis, CPU time for computationally intensive calculations, data storage, and training. The Resource coordinates its activities and directions closely with those of caBIG and NCI initiatives. in integrative research. The importance of the Bioinformatics Shared Resource within DCCI and at Duke has amplified with the explosion of genomic, proteomic, metabolomic, and other high-throughput data types;these data carry vast potential utility for clinical and translational research, especially when combined with Clinic l, imaging, and other scientific data. lni ially, this core focused on supporting DCCI studies involving DNA sequence and microarray gene expression data;we developed software and tools for visualization, c:tata mining, and annotation, first for individual research projects and then extrapolated for the general heds of genomics studies. Using microarray data as a starting point in a series of trials, we have honed our ability to integrate complex """"""""-omic"""""""" data into clinical trials. We have also developed caBIG infrastructure and tools, and controlled vocabularies. These capabilities, and our team which now possesses reqi..Jisite skills and experience, position us at the center of a distributed knowledge transfer system that links the DCCI, Institute or Genome Sciences and Policy, Shared Resources, and Duke Translational Medicifle Institute, and the caBIG infrastructure and National Bioinformatics Strategy. We have strengthened our role with each of these entities. The Bioinformatics Shared Resource functions as a service and knowledge vector through which we are transferring lessons learned in bioinformatics and """"""""-omic"""""""" sciences, and the benefits of new technological capabilities, to users across DCCI. Investigators spanning scientific disciplines that use high;.dimensional bioinformatics data (e.g., genomics, metabolomics, proteomics) can leverage our expertise to increase the uality and efficiency of complex, integrative, collaborative cancer research.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
United States
Zip Code
Lu, Min; Sanderson, Sydney M; Zessin, Amelia et al. (2018) Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer. Cancer Metab 6:14
Qian, Danwen; Liu, Hongliang; Wang, Xiaomeng et al. (2018) Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival. Int J Cancer :
Ashcraft, Kathleen A; Choudhury, Kingshuk Roy; Birer, Sam R et al. (2018) Application of a Novel Murine Ear Vein Model to Evaluate the Effects of a Vascular Radioprotectant on Radiation-Induced Vascular Permeability and Leukocyte Adhesion. Radiat Res 190:12-21
Ong, Cecilia T; Campbell, Brittany M; Thomas, Samantha M et al. (2018) Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database. Ann Surg Oncol 25:2249-2260
Duan, Bensong; Hu, Jiangfeng; Liu, Hongliang et al. (2018) Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk. Int J Cancer 142:1322-1331
Wu, Mengxi; Huang, Po-Hsun; Zhang, Rui et al. (2018) Circulating Tumor Cell Phenotyping via High-Throughput Acoustic Separation. Small 14:e1801131
Vlahovic, Gordana; Meadows, Kellen L; Hatch, Ace J et al. (2018) A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist 23:782-790
Xu, Yinghui; Liu, Hongliang; Liu, Shun et al. (2018) Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. Int J Cancer 143:2400-2408
Feng, Yun; Wang, Yanru; Liu, Hongliang et al. (2018) Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol Carcinog 57:216-224
Naqvi, Ibtehaj; Gunaratne, Ruwan; McDade, Jessica E et al. (2018) Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. Mol Ther 26:1020-1031

Showing the most recent 10 out of 513 publications